Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)
NCT ID: NCT00163514
Last Updated: 2016-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
636 participants
INTERVENTIONAL
2004-05-31
2005-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ciclesonide
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History and diagnosis of perennial allergic rhinitis by skin prick test
* Parent/caregiver must be capable of understanding the requirements, risks, and benefits of study participation, and, as judged by the investigator, capable of giving informed consent and comply with all study requirements (visits, record-keeping, etc.)
Exclusion Criteria
* Use of any prohibited concomitant medications as defined by the study protocol
* Non-vaccinated exposure to, or active infection with, chickenpox or measles within the 21 days preceding the Screening Visit
6 Years
11 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AstraZeneca AstraZeneca
Role: STUDY_DIRECTOR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Altana Pharma/Nycomed
Oxford, Alabama, United States
Altana Pharma/Nycomed
Huntington Beach, California, United States
Altana Pharma/Nycomed
Mission Viejo, California, United States
Altana Pharma/Nycomed
Newport Beach, California, United States
Altana Pharma/Nycomed
Orange, California, United States
Altana Pharma/Nycomed
Palmdale, California, United States
Altana Pharma/Nycomed
San Diego, California, United States
Altana Pharma/Nycomed
San Diego, California, United States
Altana Pharma/Nycomed
San Jose, California, United States
Altana Pharma/Nycomed
Stockton, California, United States
Altana Pharma/Nycomed
Walnut Creek, CA, California, United States
Altana Pharma/Nycomed
Coral Gables, Florida, United States
Altana Pharma/Nycomed
Ocala, Florida, United States
Altana Pharma/Nycomed
Atlanta, Georgia, United States
Altana Pharma/Nycomed
Gainesville, Georgia, United States
Altana Pharma/Nycomed
Savannah, Georgia, United States
Altana Pharma/Nycomed
Normal, Illinois, United States
Altana Pharma/Nycomed
Indianapolis, Indiana, United States
Altana Pharma/Nycomed
Dubuque, Iowa, United States
Altana Pharma/Nycomed
Overland Park, Kansas, United States
Altana Pharma/Nycomed
Metairie, Louisiana, United States
Altana Pharma/Nycomed
Shreveport, Louisiana, United States
Altana Pharma/Nycomed
Rockville, Maryland, United States
Altana Pharma/Nycomed
Wheaton, Maryland, United States
Altana Pharma/Nycomed
North Dartmouth, Massachusetts, United States
Altana Pharma/Nycomed
Minneapolis, Minnesota, United States
Altana Pharma/Nycomed
Jefferson City, Missouri, United States
Altana Pharma/Nycomed
Rolla, Mo, Missouri, United States
Altana Pharma/Nycomed
St Louis, Missouri, United States
Altana Pharma/Nycomed
Papillion, Nebraska, United States
Altana Pharma/Nycomed
Brick, New Jersey, United States
Altana Pharma/Nycomed
Skillman, New Jersey, United States
Altana Pharma/Nycomed
Liverpool, New York, United States
Altana Pharma/Nycomed
Raleigh, North Carolina, United States
Altana Pharma/Nycomed
Canton, Ohio, United States
Altana Pharma/Nycomed
Cincinnati, OH, Ohio, United States
Altana Pharma/Nycomed
Sylvania, Ohio, United States
Altana Pharma/Nycomed
Medford, Oregon, United States
Altana Pharma/Nycomed
Portland, Oregon, United States
Altana Pharma/Nycomed
Easton, Pennsylvania, United States
Altana Pharma/Nycomed
Hershey, Pennsylvania, United States
Altana Pharma/Nycomed
Upland, Pennsylvania, United States
Altana Pharma/Nycomed
Charleston, South Carolina, United States
Altana Pharma/Nycomed
Charleston, South Carolina, United States
Altana Pharma/Nycomed
Moncks Corner, South Carolina, United States
Altana Pharma/Nycomed
Spartanburg, South Carolina, United States
Altana Pharma/Nycomed
Austin, Texas, United States
Altana Pharma/Nycomed
El Paso, Texas, United States
Altana Pharma/Nycomed
Fort Worth, Texas, United States
Altana Pharma/Nycomed
Friendswood, Texas, United States
Altana Pharma/Nycomed
Houston, Texas, United States
Altana Pharma/Nycomed
Katy, Texas, United States
Altana Pharma/Nycomed
Salt Lake City, Utah, United States
Altana Pharma/Nycomed
South Burlington, Vermont, United States
Altana Pharma/Nycomed
Burke, Virginia, United States
Altana Pharma/Nycomed
Richmond, Virginia, United States
Altana Pharma/Nycomed
Richmond, Virginia, United States
Altana Pharma/Nycomed
Spokane, Washington, United States
Altana Pharma/Nycomed
Hamilton, , Canada
Altana Pharma/Nycomed
Hamilton, on, , Canada
Altana Pharma/Nycomed
Kanata, on, , Canada
Altana Pharma/Nycomed
London, , Canada
Altana Pharma/Nycomed
London,ON, , Canada
Altana Pharma/Nycomed
Mississauga, , Canada
Altana Pharma/Nycomed
Montreal, QC, , Canada
Altana Pharma/Nycomed
Niagara Falls, , Canada
Altana Pharma/Nycomed
Oshawa, on, , Canada
Altana Pharma/Nycomed
Ottawa, , Canada
Altana Pharma/Nycomed
Ottawa, on, , Canada
Altana Pharma/Nycomed
Saskatoon,SK, , Canada
Altana Pharma/Nycomed
Ste-Foy PQ, , Canada
Altana Pharma/Nycomed
Toronto, , Canada
Altana Pharma/Nycomed
Toronto, on, , Canada
Altana Pharma/Nycomed
Winnipeg, , Canada
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
BY9010-M1-403-RDS-2005-12-09.pdf
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BY9010/M1-403
Identifier Type: -
Identifier Source: org_study_id